Skip to content
Pharma in silica

Pharma in silica

Toward Refined Treatments of Solid Tumors
  • Home
  • News
  • Contact Us
  • FrançaisFrançais

Month: June 2022

Pharma in silica launches its first preclinical program

June 1, 2022 pharma in silica

Pharma in silica is initiating the preclinical study of its product candidate OpPacli™ (optimized paclitaxel) against non-small cell lung cancer (NSCLC).

Continue Reading →

Recent Posts

  • $ 2M toward an efficient and lenient chemotherapy: the government of Québec and 6 individual investors enter the capital of Pharma in silica
  • Ms. Isabelle Tremblay joins the Board of Directors of Pharma in silica
  • Pharma in silica acquires the founding intellectual property on the OpKemo technology

Archives

  • May 2023
  • December 2022
  • July 2022
  • June 2022
  • April 2022
  • July 2021
  • November 2020
  • February 2020
  • November 2019
  • August 2019

Address

  • Pharma in silica Laboratories
    Parc-Technologique Blvd
    Quebec City (Quebec) G1P 4S6
    Canada
Copyright © Pharma in silica inc. 2023